Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Apr;48(4):304–307. doi: 10.1136/jcp.48.4.304

Effects of treatment on the histopathology of leprosy.

I A Cree 1, G Coghill 1, A M Subedi 1, N C Abbot 1, S R Butlin 1, P D Samson 1, J S Beck 1
PMCID: PMC502545  PMID: 7615846

Abstract

AIMS--To identify the histological changes in leprosy skin lesions over the first few weeks after the start of leprosy treatment and to examine their relationship to reversal reaction. METHODS--Sequential skin biopsy during treatment with multiple drug therapy. In this study, a series of 28 patients was studied, from whom two or more biopsies were taken at two week intervals. Fourteen patients had paucibacillary leprosy (PBL) and 14 had multibacillary leprosy (MBL). RESULTS--In most cases, granuloma fraction and bacterial index fell during treatment, the bacterial index being less sensitive than the granuloma fraction. Since the biopsies were fixed in buffered formalin and processed through to paraffin wax, little immunohistochemistry was feasible. However, there was strong evidence of immune activation, with increased expression of HLA-DR in the granulomas of MBL and PBL cases: the epidermis also expressed HLA-DR in several patients. Such changes may reflect gamma IFN production from granuloma lymphocytes. Patients with reversal reaction often showed HLA-DR expression on admission which decreased with corticosteroid treatment. CONCLUSIONS--The results suggest that activation of cell mediated immunity in leprosy lesions occurs during treatment with multiple drug therapy and may not be restricted to those with clinical evidence of reversal reaction.

Full text

PDF
304

Images in this article

305Image
on p.305
305Image
on p.305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agusni I., Beck J. S., Potts R. C., Cree I. A., Ilias M. I. Blood flow velocity in cutaneous lesions of leprosy. Int J Lepr Other Mycobact Dis. 1988 Sep;56(3):394–400. [PubMed] [Google Scholar]
  2. Arnoldi J., Gerdes J., Flad H. D. Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol. 1990 Oct;137(4):749–753. [PMC free article] [PubMed] [Google Scholar]
  3. Beck J. S., Abbot N. C., Samson P. D., Butlin C. R., Grange J. M., Cree I. A., Forster A., Khan F. Impairment of vasomotor reflexes in the fingertips of leprosy patients. J Neurol Neurosurg Psychiatry. 1991 Nov;54(11):965–971. doi: 10.1136/jnnp.54.11.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collings L. A., Tidman N., Poulter L. W. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy. Clin Exp Immunol. 1985 Jul;61(1):58–66. [PMC free article] [PubMed] [Google Scholar]
  5. Cree I. A., Smith W. C., Rees R. J., Beck J. S. The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients. Lepr Rev. 1988 Jun;59(2):145–151. doi: 10.5935/0305-7518.19880019. [DOI] [PubMed] [Google Scholar]
  6. Cree I. A., Srinivasan T., Krishnan S. A., Gardiner C. A., Mehta J., Fisher C. A., Beck J. S. Reproducibility of histology in leprosy lesions. Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):296–301. [PubMed] [Google Scholar]
  7. Desai S. D., Birdi T. J., Antia N. H. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals. Infect Immun. 1989 Apr;57(4):1311–1317. doi: 10.1128/iai.57.4.1311-1317.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duncan M. E., Melsom R., Pearson J. M., Ridley D. S. The association of pregnancy and leprosy. I. New cases, relapse of cured patients and deterioration in patients on treatment during pregnancy and lactation--results of a prospective study of 154 pregnancies in 147 Ethiopian women. Lepr Rev. 1981 Sep;52(3):245–262. doi: 10.5935/0305-7518.19810035. [DOI] [PubMed] [Google Scholar]
  9. Job C. K. Nerve damage in leprosy. Int J Lepr Other Mycobact Dis. 1989 Jun;57(2):532–539. [PubMed] [Google Scholar]
  10. Kaplan G., Nusrat A., Sarno E. N., Job C. K., McElrath J., Porto J. A., Nathan C. F., Cohn Z. A. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol. 1987 Aug;128(2):345–353. [PMC free article] [PubMed] [Google Scholar]
  11. Modlin R. L., Hofman F. M., Meyer P. R., Sharma O. P., Taylor C. R., Rea T. H. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol. 1983 Mar;51(3):430–438. [PMC free article] [PubMed] [Google Scholar]
  12. Narayanan R. B., Bhutani L. K., Sharma A. K., Nath I. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies. Clin Exp Immunol. 1983 Mar;51(3):421–429. [PMC free article] [PubMed] [Google Scholar]
  13. Ridley M. J., Ridley D. S. Unique expression of HLA-DR (Ia-like) antigen in the lesions of polar tuberculoid leprosy. Lepr Rev. 1982 Dec;53(4):249–252. doi: 10.5935/0305-7518.19820030. [DOI] [PubMed] [Google Scholar]
  14. Slidders W., Hopwood D. Buffered phenol formaldehyde (pH 7.0 and pH 5.5): improved fixation in an enclosed tissue processor. Med Lab Sci. 1989 Jan;46(1):74–76. [PubMed] [Google Scholar]
  15. Tung K. S., Umland E., Matzner P., Nelson K., Schauf V., Rubin L., Wagner D., Scollard D., Vithayasai P., Vithayasai V. Soluble serum interleukin 2 receptor levels in leprosy patients. Clin Exp Immunol. 1987 Jul;69(1):10–15. [PMC free article] [PubMed] [Google Scholar]
  16. Volc-Platzer B., Kremsner P., Stemberger H., Wiedermann G. Restoration of defective cytokine activity within lepromatous leprosy lesions. Zentralbl Bakteriol. 1990 Apr;272(4):458–466. doi: 10.1016/s0934-8840(11)80047-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES